Grant of Options & PDMR Dealing

CVS Group plc

26 November 2024

 

26 November 2024

CVS Group plc

("CVS" or the "Company")

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2024/2025 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

Richard Fairman                                                       722 SAYE scheme options

Robin Alfonso                                                           700 SAYE scheme options

Paul Higgs                                                                 722 SAYE scheme options

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of  847 pence per share, representing a 10% discount to the average closing middle market price for the three dealing days prior to 1 November 2024, being the invitation date.

In response to accepted invitations, a total of 612,781 SAYE Scheme options over Ordinary Shares were granted on 26 November 2024, equating to 0.86% of the current issued ordinary share capital.  Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2028.  

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

Contacts:

CVS Group plc                                                                                                          via Camarco

Richard Fairman, CEO

Scott Morrison Group Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker)                                                     [phone]

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

Berenberg (Joint Broker)                                                                                          [phone]

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                                [phone]

Ginny Pulbrook                                                                                                           [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Richard Fairman
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options over Ordinary shares of 0.2 pence each GB00B2863827
b)	Nature of the transaction	Grant of Options under the SAYE Scheme.
c)	Price(s) and volume(s)	Price(s) Volume(s) Exercise price of 847p 722
d)	Aggregated information - Aggregated volume - Price
e)	Date of the transaction	26 November 2024
f)	Place of the transaction	Off market

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robin Alfonso
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options over Ordinary shares of 0.2 pence each GB00B2863827
b)	Nature of the transaction	Grant of Options under the SAYE Scheme.
c)	Price(s) and volume(s)	Price(s) Volume(s) Exercise price of 847p 700
d)	Aggregated information - Aggregated volume - Price
e)	Date of the transaction	26 November 2024
f)	Place of the transaction	Off market

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Paul Higgs
2	Reason for the notification
a)	Position/status	Chief Veterinary Officer & Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options over Ordinary shares of 0.2 pence each GB00B2863827
b)	Nature of the transaction	Grant of Options under the SAYE Scheme.
c)	Price(s) and volume(s)	Price(s) Volume(s) Exercise price of 847p 722
d)	Aggregated information - Aggregated volume - Price
e)	Date of the transaction	26 November 2024
f)	Place of the transaction	Off market

 

END